期刊文献+

肾损伤标志物表达、作用及不同情况下的变化 被引量:1

Expression and effect of renal injury markers and the changes under different conditions
下载PDF
导出
摘要 背景:随着新型肾损伤标志物的不断发现及其在不同肾脏疾病中的表达及作用机制的阐明,肾损伤防治取得了重要进展。目的:综述肾损伤标志物的研究进展。方法:应用计算机检索2006年1月2011年10月PubMed数据库相关文章,检索词为"renalinjury,markers",并限定文章语言种类为English。同时计算机检索2006年1月2011年10月中国期刊全文数据库相关文章,检索词为"肾损伤,标志物",并限定文章语言种类为中文。此外手工检索相关中英文会议文集。最终纳入符合标注的文献50篇。结果与结论:肾损伤标志物在不同肾疾病中的预测及表达不同,按时间、结构、功能及标本来源可将其进行不同的划分。这些标志物不仅能早期监测肾脏疾病、评估急性肾损伤,且有助于判断慢性肾损伤的转归。近年来发现的肾损伤标志物其变化均较血肌酐早,且具有较高的灵敏性和特异性,但如何筛选并应用于临床,还需深入研究其在不同个体、不同时相及不同合并症或并发症影响下的变化情况,建立肾损伤的预警平台,以期达到早期诊断和治疗肾损伤的目的。 BACKGROUND: With the development of new renal injury markers as well as the expression and mechanism in different renal diseases, an important progress has achieved in the protection of renal disease. OBJECTIVE: To summarize the research progress of renal injury markers. METHODS: The PubMed database was searched using the computer for articles published from January 2006 to October 2011 using the key words of "renal injury, markers" in English. Simultaneously, China Journal Full-text database were retrieved for articles published from January 2006 to October 2011 using the key words of "renal injury, markers" in Chinese. Besides, Conference Proceedings of English and Chinese were retrieved by hand. Finally, 50 articles were included according to the inclusion criteria. RESULTS AND CONCLUSION: The prediction and expression of the renal injury markers in different renal disease is distinct. According to time, the renal injury markers can be divided into acute and chronic kidney damage; according to the structure and function, the markers can be divided into glomerular, tubular and glomerular filtration rate; according to the source of specimen, the markers can be divided into blood, urine and tissue biopsy. These markers can not only early detect kidney disease, assess acute kidney injury and can determine the outcome of chronic renal injury. The diversification of renal injury markers is earlier than that of serum creatinine, and the renal injury markers have high sensitivity and specificity, but the screening and clinical application of renal injury markers needs further study on the changes in different individuals, different phase and different comorbidities or complications of kidney damage, and establish the early warning platform in order to achieve the purpose of early diagnosis and treatment of renal injury.
出处 《中国组织工程研究》 CAS CSCD 2012年第53期10048-10054,共7页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献50

  • 1Ronco C,Levin A,Warnock DG. Improving outcomes from acute kidney injury (AKI):Report on an initiative[J].International Journal of Artificial Organs,2007,(05):373-376.
  • 2Coca SG,Yalavarthy R,Concato J. Biomarkers for the diagnosis and risk stratification of acute kidney injury:a systematic review[J].Kidney International,2008,(09):1008-1016.
  • 3Han WK,Waikar SS,Johnson A. Urinary biomarkers in the early diagnosis of acute kidney injury[J].Kidney International,2008,(07):801-803.
  • 4Sawai K,Mukoyama M,Mori K. Expression of CCN1(CYR61) in developing,normal,and diseased human kidney[J].American Journal of Physiology-Renal Physiology,2007,(04):F1363-F1372.
  • 5Makris K,Markou N,Evodia E. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critical y il multiple trauma patients[J].Clinical Chemistry and Laboratory Medicine,2009,(01):79-82.
  • 6Bolignano D,Lacquaniti A,Coppolino G. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients[J].Kidney and Blood Pressure Research,2009,(02):91-98.
  • 7Thrailkil KM,Moreau CS,Cockrel GE. Disease and genderspecific dysregulation of NGAL and MMP-9 in type 1 diabetes mel itus[J].Endocrinology,2010,(02):336-343.
  • 8Nielsen SE,Hansen HP,Jensen BR. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year fol ow-up study[J].NEPHRON CLINICAL PRACTICE,2010,(02):c130-c135.
  • 9Nielsen SE,Andersen S,Zdunek D. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy[J].Kidney International,2011,(10):1113-1118.
  • 10Martensson J,Bel M,Oldner A. Neutrophil gelatinase-associated lipocalin in adult septic patientswith and without acute kidney injury[J].Intensive Care Medicine,2010,(08):1333-1340.

二级参考文献16

  • 1丁小明,刘晓东,田普训,薛武军.穿孔素和颗粒酶B的表达与肾移植术后急性排斥反应的关系[J].中华器官移植杂志,2005,26(6):344-346. 被引量:7
  • 2欧阳涓,姜傥.肾脏的损伤性诊断[J].中华检验医学杂志,2005,28(8):877-880. 被引量:132
  • 3孙培荣,石永兵.尿白蛋白/肌酐比值对诊断早期糖尿病肾病的价值[J].国际泌尿系统杂志,2006,26(4):573-575. 被引量:39
  • 4Blaner WS.Retinol-binding protein:the serum transport protein for vitamin A[J].Endocr Rev,1989,10(3):308-316.
  • 5Mogensen CE,Christensen CK,Vittinghus E.The stages in diabetic renal disease:with emphasis on the stage of incipient diabetic nephropathy[J].Diabetes,1983,32 (Suppl 2):64-78.
  • 6Laterza OF,Price CP,Scott MG.Cystatin C:an improved estimator of glomerular filtration rate[J].Clin Chem,2002,48(5):699-707.
  • 7Lehmann R,Schleicher ED.Molecular mechanism of diabetic nephropathy[J].Clin Chim Acta,2000,297(1-2):135-144.
  • 8Frey SK,Nagl B,Henze A,et al.Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver[J].Lipids Health Dis,2008,7(1):29.
  • 9Papavasileiou V,Liakopoulos V,Sakkas GK,et al.Serum levels of adipokine retinol-binding protein-4 in relation to renal function:response to Ziegelmeier et al[J].Diabetes Care,2008,31(4):e23.
  • 10Ziegelmeier M,Bachmann A,Seeger J,et al.Serum levels of adipokine retinol-binding protein-4 in relation to renal function[J].Diabetes Care,2007,30(10):2588-2592.

共引文献28

同被引文献22

  • 1姚于泓,陈慎仁,李恩民.中性粒细胞明胶酶相关脂质运载蛋白与肾脏疾病[J].实用医学杂志,2007,23(6):925-927. 被引量:19
  • 2Oppert M, Engel C, Brunkhorst FM, et al. Acute renal failure in patients with severe sepsis and septic shock-- significant independent risk factor for mortality: results from the German Prevalence Study [J]. Nephrol Dial Transplant, 2008, 23 (3): 904-909.
  • 3Lameire N, Van Biesen W, Vanholder R. Acute renal failure[J]. Lancet, 2005, 365 (9457): 417-430.
  • 4Van Bicsen WV, Vanholder R, Lamiere N. Defining ac- ute renal failure: RIFLE and beyond[J]. Clin J Am Soc Nephrol, 2006, 1 (6): 1314-1319.
  • 5Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guide|ines for management of severe sepsis and septic shock [J]. Intensive Care Med. 2008, 34 (1): 17-60.
  • 6Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury [J]. Crit Care, 2007, 11 (1): R31.
  • 7Chertow GM, dney injury, Burdick E, mortality, hospitalized patients [J] (11): 3365-3370. Honoru M, et al. Acute Ki- length of stay, and costs in J Am Soc Nephrol, 2005, 16.
  • 8Bellomo R Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: thesecond international consensus conference of the acute dialysis quality initiative (ADQI) group [J]. Crit Care, 2004, 8 (4): R204-R212.
  • 9Mishra J, Dent C, Tarabishi R, et al. Neutrephil gel- atlnase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery [J]. Lancet, 2005, 365 (9466): 1231-1238.
  • 10Basnakian AG. Netrin-l: a potential universal biomar- ker for acute kidney injury [J]. Am J Physiol Renal Physiol, 2008,294 (4): F729-F730.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部